Christine Eckles

Director of Business Development

Bringing over 25 years of healthcare experience and almost 10 of those specifically in clinical research with pharmaceutical companies, service providers and research sites, Christine joined Sabai as a Director of Business Development in 2023. Christine has experience with navigating complex organizations which has afforded her the opportunity to take on this leadership role to help develop the strategic growth of all of the business units. Christine’s charismatic and positive spirit and her experience as a business executive with strategic vision, allows her to understand viewpoints across various stakeholders within the organizations she works with including providers, investigators, participants, patients, CROs and Sponsors. She has extensive experience in strategic relationships, integrated complex solutions, sales leadership, and marketing.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.